LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

S. Magno, G. Ceccarini, C. Pelosini, R. Jaccheri, J. Vitti, P. Fierabracci, G. Salvetti, G. Airoldi, M. Minale, G. Saponati, F. Santini

ABSTRACT

BACKGROUND: Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may sometimes cause adverse events. A growing attention has been devoted to the correction of dyslipidemias through the use of dietary supplements. The aim of this study was to assess the lipid-lowering activity and safety of a dietary supplement containing monacolin K, L-arginine, coenzyme Q10 and ascorbic acid, named Argicolina (A), compared to a commercially available product containing monacolin K and coenzyme Q10, Normolip 5 (N). METHODS: This was a single center, controlled, randomized, open-label, cross-over clinical study enrolling 20 Caucasian outpatients aged 18-75 years with serum LDL-C between 130 and 180 mg/dL. Patients assumed two different dietary supplements (A and N) both containing monacolin K 10 mg for 8 weeks each, separated by a 4-week wash-out period. Evaluated parameters were: Total cholesterol (Tot-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, creatinekinase, gamma-glutamyl-transpeptidase, brachial arterial pressure and heart rate, measured at the start and at the end of each treatment period. Safety was monitored through the study. RESULTS: LDL-C decreased by 23.3% during treatment with N (p < 0.0001) and by 25.6% during treatment with A (p < 0.0001); the LDL-C mean reduction was 36.4 (95% CI: 45,6-27,1) mg/dL during N treatment and 40.1 (95% CI: 49.2-30,9) mg/dL during A treatment. Tot-C decreased significantly (p < 0.0001) within each treatment period. HDL-C increase was negligible during A whereas it was significant during N. TG diminished markedly during A and not significantly during N. The difference between treatments was not statistically significant for all variables. No serious or severe adverse events occurred during the study. CONCLUSIONS: Our results confirm the clinically meaningful LDL-C lowering properties of monacolin K. At variance with a supplement already in the market (N), the novel association (A) of monacolin K with L-arginine, coenzime Q10 and ascorbic acid also produces a significant reduction of triglycerides without significant effects on HDL. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT03425630 . More... »

PAGES

124

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12944-018-0775-8

DOI

http://dx.doi.org/10.1186/s12944-018-0775-8

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1104168536

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29793488


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1101", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical Biochemistry and Metabolomics", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adolescent", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Analysis of Variance", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Anticholesteremic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Arginine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ascorbic Acid", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, HDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cholesterol, LDL", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Over Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Dietary Supplements", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypercholesterolemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lovastatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Severity of Illness Index", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Triglycerides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ubiquinone", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Magno", 
        "givenName": "S.", 
        "id": "sg:person.01346066015.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346066015.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ceccarini", 
        "givenName": "G.", 
        "id": "sg:person.01171104613.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171104613.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pelosini", 
        "givenName": "C.", 
        "id": "sg:person.0661622357.30", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661622357.30"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Jaccheri", 
        "givenName": "R.", 
        "id": "sg:person.011305273355.02", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011305273355.02"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vitti", 
        "givenName": "J.", 
        "id": "sg:person.012102653755.73", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102653755.73"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fierabracci", 
        "givenName": "P.", 
        "id": "sg:person.01302451207.28", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302451207.28"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Salvetti", 
        "givenName": "G.", 
        "id": "sg:person.01313770306.19", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313770306.19"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Studio Associato Airoldi Cicogna Ghirri, Via Manzoni 40, Milan, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Airoldi", 
        "givenName": "G.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ISPharm srl, Via Oberdan 43, Lucca, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Minale", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "ISPharm srl, Via Oberdan 43, Lucca, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saponati", 
        "givenName": "G.", 
        "id": "sg:person.01013541553.51", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013541553.51"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Santini", 
        "givenName": "F.", 
        "id": "sg:person.01226525757.06", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226525757.06"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1371/journal.pone.0098611", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004485213"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-511x-12-119", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005059588", 
          "https://doi.org/10.1186/1476-511x-12-119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejphar.2011.08.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007322958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3389/fphar.2012.00141", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007624479"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/07853890.2011.582135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007687180"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0101978", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015564126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0101978", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015564126"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3945/ajcn.2008.26544", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016193582"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(05)67394-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016524401"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.atherosclerosissup.2016.10.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023963941"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci115987", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025078708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ctim.2012.07.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026372392"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/ncpcardio0878", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026409341", 
          "https://doi.org/10.1038/ncpcardio0878"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10715760500104025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028977678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1080/10715760500104025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028977678"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacc.2013.11.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031012810"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0021-9150(96)05953-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032306540"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.amjcard.2008.02.056", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035975365"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jacl.2013.11.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037507234"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1089/jmf.2015.0024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039467136"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nutres.2013.05.015", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039803952"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nutres.2009.04.004", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040238048"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nm1008-1050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041627528", 
          "https://doi.org/10.1038/nm1008-1050"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehw106", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041809009"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12325-011-0082-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042152551", 
          "https://doi.org/10.1007/s12325-011-0082-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s40292-015-0092-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042460972", 
          "https://doi.org/10.1007/s40292-015-0092-5"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.nmd.2013.09.011", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046666509"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.curtheres.2014.07.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046930375"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/eje.1.02012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047173568"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/14651858.cd010405.pub2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048794257"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/cvr/23.12.1053", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1059486886"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjr.0b013e32832f3a76", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060341621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/hjr.0b013e32832f3a76", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1060341621"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1161/01.cir.95.2.311", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1063337740"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.7326/0003-4819-150-12-200906160-00006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1073710498"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/foods6030019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084435526"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may sometimes cause adverse events. A growing attention has been devoted to the correction of dyslipidemias through the use of dietary supplements. The aim of this study was to assess the lipid-lowering activity and safety of a dietary supplement containing monacolin K, L-arginine, coenzyme Q10 and ascorbic acid, named Argicolina (A), compared to a commercially available product containing monacolin K and coenzyme Q10, Normolip 5 (N).\nMETHODS: This was a single center, controlled, randomized, open-label, cross-over clinical study enrolling 20 Caucasian outpatients aged 18-75\u00a0years with serum LDL-C between 130 and 180\u00a0mg/dL. Patients assumed two different dietary supplements (A and N) both containing monacolin K 10\u00a0mg for 8\u00a0weeks each, separated by a 4-week wash-out period. Evaluated parameters were: Total cholesterol (Tot-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, creatinekinase, gamma-glutamyl-transpeptidase, brachial arterial pressure and heart rate, measured at the start and at the end of each treatment period. Safety was monitored through the study.\nRESULTS: LDL-C decreased by 23.3% during treatment with N (p\u00a0<\u00a00.0001) and by 25.6% during treatment with A (p\u00a0<\u00a00.0001); the LDL-C mean reduction was 36.4 (95% CI: 45,6-27,1) mg/dL during N treatment and 40.1 (95% CI: 49.2-30,9) mg/dL during A treatment. Tot-C decreased significantly (p\u00a0<\u00a00.0001) within each treatment period. HDL-C increase was negligible during A whereas it was significant during N. TG diminished markedly during A and not significantly during N. The difference between treatments was not statistically significant for all variables. No serious or severe adverse events occurred during the study.\nCONCLUSIONS: Our results confirm the clinically meaningful LDL-C lowering properties of monacolin K. At variance with a supplement already in the market (N), the novel association (A) of monacolin K with L-arginine, coenzime Q10 and ascorbic acid also produces a significant reduction of triglycerides without significant effects on HDL.\nTRIAL REGISTRATION: ClinicalTrials.gov ID: NCT03425630 .", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12944-018-0775-8", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031029", 
        "issn": [
          "1476-511X"
        ], 
        "name": "Lipids in Health and Disease", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "17"
      }
    ], 
    "name": "LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia", 
    "pagination": "124", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2c4f999c5ef5ae2c62b19fd73e33b6f4fdff4ff73e3db8a7a4c87cca5733d2a4"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29793488"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101147696"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12944-018-0775-8"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1104168536"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12944-018-0775-8", 
      "https://app.dimensions.ai/details/publication/pub.1104168536"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T16:55", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8669_00000604.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12944-018-0775-8"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12944-018-0775-8'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12944-018-0775-8'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12944-018-0775-8'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12944-018-0775-8'


 

This table displays all metadata directly associated to this object as RDF triples.

339 TRIPLES      21 PREDICATES      82 URIs      41 LITERALS      29 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12944-018-0775-8 schema:about N04604f6519c14a07aa7cd0dd67b74add
2 N13d8326627e24705a5cbb9d9363e7ce5
3 N1a157b144f184a349f3778fd688bd352
4 N21ff0b25695c48a18dd38f2073cec653
5 N23e812c003e7417ab49d90aea35d466c
6 N3b4c551fab2e458d99515ffefc35491a
7 N4128ea3bd5304afdbf3db5af85e40c07
8 N447c5e21c7e24d72bd3c3c83e68385cf
9 N53eff1aee4884d52ab67343b0b7ec9e4
10 N5a7f93e7358f4f409379a836ed60149f
11 N72e77a7edccc447897e76dace366916d
12 N8deb44c8dccb438bb6eb1ce1b4d4e505
13 N9aa471e5dc4f4874a90bf4659d6fac53
14 N9fc7d3943899472ba8c524c52fe5ae60
15 Na2e539aeb835446187bcab4f8e846755
16 Nad7d9e97c5af4231abeddf4404f46490
17 Nbacd25b049064c54ab8ab85bcb6e26f0
18 Ne52f39ce1fc944df947b11586c793d55
19 Ne78fb34811474263a5935336f5590d92
20 Nf5d9f98e910c48899ef91e8869be5f8d
21 anzsrc-for:11
22 anzsrc-for:1101
23 schema:author Nd3386701f1bd4340ae24910e62d1572a
24 schema:citation sg:pub.10.1007/s12325-011-0082-5
25 sg:pub.10.1007/s40292-015-0092-5
26 sg:pub.10.1038/ncpcardio0878
27 sg:pub.10.1038/nm1008-1050
28 sg:pub.10.1186/1476-511x-12-119
29 https://doi.org/10.1002/14651858.cd010405.pub2
30 https://doi.org/10.1016/j.amjcard.2008.02.056
31 https://doi.org/10.1016/j.atherosclerosissup.2016.10.003
32 https://doi.org/10.1016/j.ctim.2012.07.004
33 https://doi.org/10.1016/j.curtheres.2014.07.003
34 https://doi.org/10.1016/j.ejphar.2011.08.018
35 https://doi.org/10.1016/j.jacc.2013.11.002
36 https://doi.org/10.1016/j.jacl.2013.11.003
37 https://doi.org/10.1016/j.nmd.2013.09.011
38 https://doi.org/10.1016/j.nutres.2009.04.004
39 https://doi.org/10.1016/j.nutres.2013.05.015
40 https://doi.org/10.1016/s0021-9150(96)05953-9
41 https://doi.org/10.1016/s0140-6736(05)67394-1
42 https://doi.org/10.1080/10715760500104025
43 https://doi.org/10.1089/jmf.2015.0024
44 https://doi.org/10.1093/cvr/23.12.1053
45 https://doi.org/10.1093/eurheartj/ehw106
46 https://doi.org/10.1097/hjr.0b013e32832f3a76
47 https://doi.org/10.1161/01.cir.95.2.311
48 https://doi.org/10.1172/jci115987
49 https://doi.org/10.1371/journal.pone.0098611
50 https://doi.org/10.1371/journal.pone.0101978
51 https://doi.org/10.1530/eje.1.02012
52 https://doi.org/10.3109/07853890.2011.582135
53 https://doi.org/10.3389/fphar.2012.00141
54 https://doi.org/10.3390/foods6030019
55 https://doi.org/10.3945/ajcn.2008.26544
56 https://doi.org/10.7326/0003-4819-150-12-200906160-00006
57 schema:datePublished 2018-12
58 schema:datePublishedReg 2018-12-01
59 schema:description BACKGROUND: Hypercholesterolemia is a major risk factor for cardiovascular disorders and requires specific intervention through an adequate lifestyle (diet and physical exercise) and, if necessary, an appropriate drug treatment. Lipid-lowering drugs, although generally efficacious, may sometimes cause adverse events. A growing attention has been devoted to the correction of dyslipidemias through the use of dietary supplements. The aim of this study was to assess the lipid-lowering activity and safety of a dietary supplement containing monacolin K, L-arginine, coenzyme Q10 and ascorbic acid, named Argicolina (A), compared to a commercially available product containing monacolin K and coenzyme Q10, Normolip 5 (N). METHODS: This was a single center, controlled, randomized, open-label, cross-over clinical study enrolling 20 Caucasian outpatients aged 18-75 years with serum LDL-C between 130 and 180 mg/dL. Patients assumed two different dietary supplements (A and N) both containing monacolin K 10 mg for 8 weeks each, separated by a 4-week wash-out period. Evaluated parameters were: Total cholesterol (Tot-C), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), triglycerides (TG), fasting blood glucose, aspartate aminotransferase, alanine aminotransferase, creatinekinase, gamma-glutamyl-transpeptidase, brachial arterial pressure and heart rate, measured at the start and at the end of each treatment period. Safety was monitored through the study. RESULTS: LDL-C decreased by 23.3% during treatment with N (p < 0.0001) and by 25.6% during treatment with A (p < 0.0001); the LDL-C mean reduction was 36.4 (95% CI: 45,6-27,1) mg/dL during N treatment and 40.1 (95% CI: 49.2-30,9) mg/dL during A treatment. Tot-C decreased significantly (p < 0.0001) within each treatment period. HDL-C increase was negligible during A whereas it was significant during N. TG diminished markedly during A and not significantly during N. The difference between treatments was not statistically significant for all variables. No serious or severe adverse events occurred during the study. CONCLUSIONS: Our results confirm the clinically meaningful LDL-C lowering properties of monacolin K. At variance with a supplement already in the market (N), the novel association (A) of monacolin K with L-arginine, coenzime Q10 and ascorbic acid also produces a significant reduction of triglycerides without significant effects on HDL. TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT03425630 .
60 schema:genre research_article
61 schema:inLanguage en
62 schema:isAccessibleForFree true
63 schema:isPartOf N5229d69034f0466b9853dc6cec31acaf
64 Nced7fbc7114c49caab9a60fb9f54f5a3
65 sg:journal.1031029
66 schema:name LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
67 schema:pagination 124
68 schema:productId N8a6afd8d275643e6b0cd4baa4bf8b824
69 N928b87f0e2ee4419a1c34dd03208ba47
70 N99b693b042f54d7f8438cf24a170a9ab
71 Na3dd8944258a4f6ca648c1b40098eaf0
72 Na5f48b7c20ae421dac6bdaeef98fb8e1
73 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104168536
74 https://doi.org/10.1186/s12944-018-0775-8
75 schema:sdDatePublished 2019-04-10T16:55
76 schema:sdLicense https://scigraph.springernature.com/explorer/license/
77 schema:sdPublisher Nd6122a7fcee14dc5bc60851a2343ff1a
78 schema:url https://link.springer.com/10.1186%2Fs12944-018-0775-8
79 sgo:license sg:explorer/license/
80 sgo:sdDataset articles
81 rdf:type schema:ScholarlyArticle
82 N04604f6519c14a07aa7cd0dd67b74add schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
83 schema:name Cross-Over Studies
84 rdf:type schema:DefinedTerm
85 N090678634b8c4290a14097b1a92167df schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
86 rdf:type schema:Organization
87 N1288fb77e7174711b8aeba539d59d805 rdf:first Ncb301173813d4bfab440968904883409
88 rdf:rest N740afbb5a021469f8d4ecece3177f907
89 N13d8326627e24705a5cbb9d9363e7ce5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
90 schema:name Male
91 rdf:type schema:DefinedTerm
92 N1a157b144f184a349f3778fd688bd352 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Arginine
94 rdf:type schema:DefinedTerm
95 N21ff0b25695c48a18dd38f2073cec653 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Adolescent
97 rdf:type schema:DefinedTerm
98 N23e812c003e7417ab49d90aea35d466c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
99 schema:name Aged
100 rdf:type schema:DefinedTerm
101 N354cda34b9bb463f8869aa7c0973fd67 schema:name ISPharm srl, Via Oberdan 43, Lucca, Italy
102 rdf:type schema:Organization
103 N3b4c551fab2e458d99515ffefc35491a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Ascorbic Acid
105 rdf:type schema:DefinedTerm
106 N3d69d57de2b3437d9b3de74f22e69fb9 schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
107 rdf:type schema:Organization
108 N4128ea3bd5304afdbf3db5af85e40c07 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
109 schema:name Severity of Illness Index
110 rdf:type schema:DefinedTerm
111 N42a19a50ffa142ecb90d51cb88fe16b0 rdf:first sg:person.0661622357.30
112 rdf:rest Nb522c3d31bd14344ac19bdf6ff0f51e7
113 N447c5e21c7e24d72bd3c3c83e68385cf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Adult
115 rdf:type schema:DefinedTerm
116 N49cc4b22c3494fe8af8e5e0b3af7b0e6 schema:name ISPharm srl, Via Oberdan 43, Lucca, Italy
117 rdf:type schema:Organization
118 N5229d69034f0466b9853dc6cec31acaf schema:volumeNumber 17
119 rdf:type schema:PublicationVolume
120 N53eff1aee4884d52ab67343b0b7ec9e4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Hypercholesterolemia
122 rdf:type schema:DefinedTerm
123 N5a7f93e7358f4f409379a836ed60149f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Analysis of Variance
125 rdf:type schema:DefinedTerm
126 N72e77a7edccc447897e76dace366916d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Middle Aged
128 rdf:type schema:DefinedTerm
129 N740afbb5a021469f8d4ecece3177f907 rdf:first sg:person.01013541553.51
130 rdf:rest Ne30768270d39423185d36ef1d928eb97
131 N7d8e8e61e1f34cbfb67dca5083125f6f schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
132 rdf:type schema:Organization
133 N8a6afd8d275643e6b0cd4baa4bf8b824 schema:name dimensions_id
134 schema:value pub.1104168536
135 rdf:type schema:PropertyValue
136 N8deb44c8dccb438bb6eb1ce1b4d4e505 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Humans
138 rdf:type schema:DefinedTerm
139 N91d3ed4393db42e893f98b5b14994d8d schema:affiliation Nf9b7595de6ff480c96b53d0cc0e51782
140 schema:familyName Airoldi
141 schema:givenName G.
142 rdf:type schema:Person
143 N928b87f0e2ee4419a1c34dd03208ba47 schema:name nlm_unique_id
144 schema:value 101147696
145 rdf:type schema:PropertyValue
146 N99b693b042f54d7f8438cf24a170a9ab schema:name doi
147 schema:value 10.1186/s12944-018-0775-8
148 rdf:type schema:PropertyValue
149 N9aa471e5dc4f4874a90bf4659d6fac53 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Ubiquinone
151 rdf:type schema:DefinedTerm
152 N9b02daa7c42540928daef1d7015d2629 schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
153 rdf:type schema:Organization
154 N9b363845a7124abe981153d9433e7628 rdf:first N91d3ed4393db42e893f98b5b14994d8d
155 rdf:rest N1288fb77e7174711b8aeba539d59d805
156 N9fc7d3943899472ba8c524c52fe5ae60 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Cholesterol, HDL
158 rdf:type schema:DefinedTerm
159 Na2e539aeb835446187bcab4f8e846755 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Triglycerides
161 rdf:type schema:DefinedTerm
162 Na3d6b3248dff4d399b0e7769d3146efa rdf:first sg:person.01302451207.28
163 rdf:rest Na9edffb351e1438aa0763f57ac1159ca
164 Na3dd8944258a4f6ca648c1b40098eaf0 schema:name readcube_id
165 schema:value 2c4f999c5ef5ae2c62b19fd73e33b6f4fdff4ff73e3db8a7a4c87cca5733d2a4
166 rdf:type schema:PropertyValue
167 Na5f48b7c20ae421dac6bdaeef98fb8e1 schema:name pubmed_id
168 schema:value 29793488
169 rdf:type schema:PropertyValue
170 Na9edffb351e1438aa0763f57ac1159ca rdf:first sg:person.01313770306.19
171 rdf:rest N9b363845a7124abe981153d9433e7628
172 Nad7d9e97c5af4231abeddf4404f46490 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Anticholesteremic Agents
174 rdf:type schema:DefinedTerm
175 Nb3e06291a29346a2bd4427495876dbaa schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
176 rdf:type schema:Organization
177 Nb522c3d31bd14344ac19bdf6ff0f51e7 rdf:first sg:person.011305273355.02
178 rdf:rest Nc497d783cc114ff6a72d4ff570861a4b
179 Nb8e80699f99343a48afeb0259a3c943e schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
180 rdf:type schema:Organization
181 Nbacd25b049064c54ab8ab85bcb6e26f0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Female
183 rdf:type schema:DefinedTerm
184 Nc497d783cc114ff6a72d4ff570861a4b rdf:first sg:person.012102653755.73
185 rdf:rest Na3d6b3248dff4d399b0e7769d3146efa
186 Nc6d45a68e6d54fc6b8d002d67945e36d schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
187 rdf:type schema:Organization
188 Nc7195a0121ee46ec982898bb2f495981 schema:name Obesity Center at the Endocrinology Unit, University Hospital of Pisa, Via Paradisa 2, Pisa, Italy
189 rdf:type schema:Organization
190 Ncb301173813d4bfab440968904883409 schema:affiliation N49cc4b22c3494fe8af8e5e0b3af7b0e6
191 schema:familyName Minale
192 schema:givenName M.
193 rdf:type schema:Person
194 Nced7fbc7114c49caab9a60fb9f54f5a3 schema:issueNumber 1
195 rdf:type schema:PublicationIssue
196 Nd3386701f1bd4340ae24910e62d1572a rdf:first sg:person.01346066015.63
197 rdf:rest Nd8df79bbd4224a55b059b50a1d1de4c4
198 Nd6122a7fcee14dc5bc60851a2343ff1a schema:name Springer Nature - SN SciGraph project
199 rdf:type schema:Organization
200 Nd8df79bbd4224a55b059b50a1d1de4c4 rdf:first sg:person.01171104613.28
201 rdf:rest N42a19a50ffa142ecb90d51cb88fe16b0
202 Ne30768270d39423185d36ef1d928eb97 rdf:first sg:person.01226525757.06
203 rdf:rest rdf:nil
204 Ne52f39ce1fc944df947b11586c793d55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
205 schema:name Dietary Supplements
206 rdf:type schema:DefinedTerm
207 Ne78fb34811474263a5935336f5590d92 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
208 schema:name Lovastatin
209 rdf:type schema:DefinedTerm
210 Nf5d9f98e910c48899ef91e8869be5f8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
211 schema:name Cholesterol, LDL
212 rdf:type schema:DefinedTerm
213 Nf9b7595de6ff480c96b53d0cc0e51782 schema:name Studio Associato Airoldi Cicogna Ghirri, Via Manzoni 40, Milan, Italy
214 rdf:type schema:Organization
215 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
216 schema:name Medical and Health Sciences
217 rdf:type schema:DefinedTerm
218 anzsrc-for:1101 schema:inDefinedTermSet anzsrc-for:
219 schema:name Medical Biochemistry and Metabolomics
220 rdf:type schema:DefinedTerm
221 sg:journal.1031029 schema:issn 1476-511X
222 schema:name Lipids in Health and Disease
223 rdf:type schema:Periodical
224 sg:person.01013541553.51 schema:affiliation N354cda34b9bb463f8869aa7c0973fd67
225 schema:familyName Saponati
226 schema:givenName G.
227 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01013541553.51
228 rdf:type schema:Person
229 sg:person.011305273355.02 schema:affiliation Nc7195a0121ee46ec982898bb2f495981
230 schema:familyName Jaccheri
231 schema:givenName R.
232 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011305273355.02
233 rdf:type schema:Person
234 sg:person.01171104613.28 schema:affiliation N7d8e8e61e1f34cbfb67dca5083125f6f
235 schema:familyName Ceccarini
236 schema:givenName G.
237 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01171104613.28
238 rdf:type schema:Person
239 sg:person.012102653755.73 schema:affiliation Nc6d45a68e6d54fc6b8d002d67945e36d
240 schema:familyName Vitti
241 schema:givenName J.
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012102653755.73
243 rdf:type schema:Person
244 sg:person.01226525757.06 schema:affiliation N9b02daa7c42540928daef1d7015d2629
245 schema:familyName Santini
246 schema:givenName F.
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226525757.06
248 rdf:type schema:Person
249 sg:person.01302451207.28 schema:affiliation N3d69d57de2b3437d9b3de74f22e69fb9
250 schema:familyName Fierabracci
251 schema:givenName P.
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302451207.28
253 rdf:type schema:Person
254 sg:person.01313770306.19 schema:affiliation N090678634b8c4290a14097b1a92167df
255 schema:familyName Salvetti
256 schema:givenName G.
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313770306.19
258 rdf:type schema:Person
259 sg:person.01346066015.63 schema:affiliation Nb8e80699f99343a48afeb0259a3c943e
260 schema:familyName Magno
261 schema:givenName S.
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01346066015.63
263 rdf:type schema:Person
264 sg:person.0661622357.30 schema:affiliation Nb3e06291a29346a2bd4427495876dbaa
265 schema:familyName Pelosini
266 schema:givenName C.
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0661622357.30
268 rdf:type schema:Person
269 sg:pub.10.1007/s12325-011-0082-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042152551
270 https://doi.org/10.1007/s12325-011-0082-5
271 rdf:type schema:CreativeWork
272 sg:pub.10.1007/s40292-015-0092-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042460972
273 https://doi.org/10.1007/s40292-015-0092-5
274 rdf:type schema:CreativeWork
275 sg:pub.10.1038/ncpcardio0878 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026409341
276 https://doi.org/10.1038/ncpcardio0878
277 rdf:type schema:CreativeWork
278 sg:pub.10.1038/nm1008-1050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041627528
279 https://doi.org/10.1038/nm1008-1050
280 rdf:type schema:CreativeWork
281 sg:pub.10.1186/1476-511x-12-119 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005059588
282 https://doi.org/10.1186/1476-511x-12-119
283 rdf:type schema:CreativeWork
284 https://doi.org/10.1002/14651858.cd010405.pub2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048794257
285 rdf:type schema:CreativeWork
286 https://doi.org/10.1016/j.amjcard.2008.02.056 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035975365
287 rdf:type schema:CreativeWork
288 https://doi.org/10.1016/j.atherosclerosissup.2016.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023963941
289 rdf:type schema:CreativeWork
290 https://doi.org/10.1016/j.ctim.2012.07.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026372392
291 rdf:type schema:CreativeWork
292 https://doi.org/10.1016/j.curtheres.2014.07.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046930375
293 rdf:type schema:CreativeWork
294 https://doi.org/10.1016/j.ejphar.2011.08.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007322958
295 rdf:type schema:CreativeWork
296 https://doi.org/10.1016/j.jacc.2013.11.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031012810
297 rdf:type schema:CreativeWork
298 https://doi.org/10.1016/j.jacl.2013.11.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037507234
299 rdf:type schema:CreativeWork
300 https://doi.org/10.1016/j.nmd.2013.09.011 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046666509
301 rdf:type schema:CreativeWork
302 https://doi.org/10.1016/j.nutres.2009.04.004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040238048
303 rdf:type schema:CreativeWork
304 https://doi.org/10.1016/j.nutres.2013.05.015 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039803952
305 rdf:type schema:CreativeWork
306 https://doi.org/10.1016/s0021-9150(96)05953-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032306540
307 rdf:type schema:CreativeWork
308 https://doi.org/10.1016/s0140-6736(05)67394-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016524401
309 rdf:type schema:CreativeWork
310 https://doi.org/10.1080/10715760500104025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028977678
311 rdf:type schema:CreativeWork
312 https://doi.org/10.1089/jmf.2015.0024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039467136
313 rdf:type schema:CreativeWork
314 https://doi.org/10.1093/cvr/23.12.1053 schema:sameAs https://app.dimensions.ai/details/publication/pub.1059486886
315 rdf:type schema:CreativeWork
316 https://doi.org/10.1093/eurheartj/ehw106 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041809009
317 rdf:type schema:CreativeWork
318 https://doi.org/10.1097/hjr.0b013e32832f3a76 schema:sameAs https://app.dimensions.ai/details/publication/pub.1060341621
319 rdf:type schema:CreativeWork
320 https://doi.org/10.1161/01.cir.95.2.311 schema:sameAs https://app.dimensions.ai/details/publication/pub.1063337740
321 rdf:type schema:CreativeWork
322 https://doi.org/10.1172/jci115987 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025078708
323 rdf:type schema:CreativeWork
324 https://doi.org/10.1371/journal.pone.0098611 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004485213
325 rdf:type schema:CreativeWork
326 https://doi.org/10.1371/journal.pone.0101978 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015564126
327 rdf:type schema:CreativeWork
328 https://doi.org/10.1530/eje.1.02012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047173568
329 rdf:type schema:CreativeWork
330 https://doi.org/10.3109/07853890.2011.582135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007687180
331 rdf:type schema:CreativeWork
332 https://doi.org/10.3389/fphar.2012.00141 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007624479
333 rdf:type schema:CreativeWork
334 https://doi.org/10.3390/foods6030019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084435526
335 rdf:type schema:CreativeWork
336 https://doi.org/10.3945/ajcn.2008.26544 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016193582
337 rdf:type schema:CreativeWork
338 https://doi.org/10.7326/0003-4819-150-12-200906160-00006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1073710498
339 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...